The lead compound 5 has been confirmed to demonstrate memory-enhancing effects in AD mouse models, exhibiting AChE and PDE5A1 inhibition at IC50 = 0.032 μM and IC50 = 1.53 μM, respectively. This evidence concerns the gene ACHE and Alzheimer disease.